|Articles|November 1, 2019
- Pharmaceutical Executive-11-01-2019
- Volume 39
- Issue 11
Pharmaceutical Executive, November 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive November 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 6 years ago
Pharm Exec’s 2020 Pipeline Reportabout 6 years ago
R. Jude Samulski: Gene Therapy’s Guiding Forceabout 6 years ago
The Pace of Massive Innovationabout 6 years ago
The Quest to Measure Drug Effectivenessabout 6 years ago
Biosensors in Pharma: A Dose of Optimismabout 6 years ago
Closing the Science and Manufacturing Divideabout 6 years ago
Country Report: SwedenNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer’s Proven Playbook: Buy, Partner, Scale, Spin-Off, Optimize
2
HHS and FDA Appoint Richard Pazdur as Director of The Center for Drug Evaluation and Research
3
AstraZeneca Stock Becomes UK’s Biggest Stock
4
Bristol Myers Squibb Expands its Strategic Collaboration with Sarah Cannon Research Institute
5
